Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 7.79% is 86% below its 2-year average of 54.47%, near the low end of its 2-year range (0.00%–398.65%).
As of the fiscal period ended Tuesday, June 30, 2026. 155.90% above its 12-month average of 3.04%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 7.79%.
DEBT TO ASSETS RATIO
7.79%
DEBT TO ASSETS RATIO AVG TTM
3.04%
DEBT TO ASSETS RATIO AVG 3Y
N/A
DEBT TO ASSETS RATIO AVG 5Y
N/A
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+155.90%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+8554.75%
vs the sector median at left
Actuate Therapeutics Inc
Market Cap
$18.64M
Debt to Assets Ratio
7.79%
TTM Avg
3.04%
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$18.67M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$18.67M
Debt to Assets Ratio
0.20%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$17.99M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$17.26M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Actuate Therapeutics Inc (ACTU) | $18.64M | 7.79% | 3.04% | N/A | N/A |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.67M | 0.00% | N/A | N/A | N/A |
| P3 Health Partners Inc. (PIII)vs › | $18.67M | 0.20% | N/A | N/A | N/A |
| Cosmos Health Inc. (COSM)vs › | $18.06M | 0.26% | N/A | N/A | N/A |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.99M | 0.00% | N/A | N/A | N/A |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.26M | 0.00% | N/A | N/A | N/A |
| PAVmed Inc. (PAVM)vs › | $17.14M | 0.42% | N/A | N/A | N/A |
| NextCure, Inc. (NXTC)vs › | $20.16M | 0.19% | N/A | N/A | N/A |
| Lipocine Inc. (LPCN)vs › | $17.11M | 0.00% | N/A | N/A | N/A |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.35M | 0.07% | N/A | N/A | N/A |
Debt/Assets
7.8%
Debt/Equity
0.41
Current Ratio
1.25
Interest Coverage
-1110.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 7.79% |
| 2026-03-31 | 4.54% |
| 2025-12-31 | 2.89% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 398.65% |
| 2024-03-31 | 185.28% |
| 2023-12-31 | 0.00% |
